New brain stimulation device shows promise for Parkinson's patients

NCT ID NCT05992701

Completed Disease control Sponsor: Beijing Pins Medical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new deep brain stimulation (DBS) system that uses directional leads to treat Parkinson's disease. 26 adults with Parkinson's whose symptoms were not well controlled by medication took part. The goal was to see if the system could improve motor function and quality of life while having a wider safety margin between helpful stimulation and side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON'S DISEASE

Contacts and locations

Locations

Beijing Tiantan Hospital, Capital Medical University

Beijing, China
Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University

Beijing, China
Changhai Hospital, the Second Military Medical University

Shanghai, China
First Affiliated Hospital of Kunming Medical University

Kunming, China
Nanjing Brain Hospital Affiliated to Nanjing Medical University

Nanjing, China
Shenzhen Second People's Hospital (the First Affiliated Hospital of Shenzhen University)

Shenzhen, China
Tianjin Medical University General Hospital

Tianjin, China
West China Hospital of Sichuan University

Chengdu, China
Zhongnan Hospital of Wuhan University

Wuhan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.